ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,717 | -59.0% | 4,146 | -77.2% | 0.00% | 0.0% |
| Q2 2020 | $587,000 | -8.1% | 18,146 | +15.8% | 0.00% | -50.0% |
| Q1 2020 | $639,000 | -57.1% | 15,673 | -35.0% | 0.00% | -50.0% |
| Q4 2019 | $1,488,000 | -15.4% | 24,127 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $1,758,000 | +544.0% | 24,127 | +627.6% | 0.01% | +400.0% |
| Q2 2019 | $273,000 | -9.6% | 3,316 | -22.6% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +24.8% | 4,286 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $242,000 | -15.4% | 4,286 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $286,000 | +31.2% | 4,286 | +14.7% | 0.00% | 0.0% |
| Q1 2018 | $218,000 | +6.9% | 3,736 | +21.7% | 0.00% | 0.0% |
| Q3 2016 | $204,000 | -0.5% | 3,071 | -32.4% | 0.00% | 0.0% |
| Q4 2015 | $205,000 | -27.3% | 4,541 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $282,000 | +21.0% | 4,541 | +21.6% | 0.00% | 0.0% |
| Q1 2015 | $233,000 | +11.5% | 3,733 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $209,000 | – | 3,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |